Peer-reviewedLicence not statedGut29 Sep 2026

Reply to ‘DR1-DR2 enrichment in HBeAg-negative chronic hepatitis B: integration hotspot or survivor signature?’

Daryl T-Y Lau¹
Ying-Hsiu Su²
Haitao Guo³

¹Liver Center, Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
²Translational Medical Science, The Baruch S. Blumberg Institute, Doylestown, Pennsylvania, USA
³Department of Microbiology and Molecular Genetics; Cancer Virology Center, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

Negative-Control Calibration and E-Value Bounding of Cancer-Survivor Mortality Contrasts: A Design-Aware Competing-Risks Analysis
Irina Naskinova, Mikhail Kolev, Meglena Lazarova +2
Cancers4 Nov 2026Peer-reviewedCC BY 4.0OncologyCrossref
An interpretable machine-learning signature predicts early triple-negative breast cancer recurrence but adds no prognostic value beyond clinicopathological factors in external validation
Haocheng Nan, Rong Di, Xiaorong Kou +1
Scientific Reports12 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
Cross-Cancer Characterization of CAMK2A Reveals Its Favorable Prognostic Association and Neuronal Signature Enrichment in Glioma.
Yimin Pan, Changwu Wu, Jun Tan +2
Biomedicines30 Sep 2026Peer-reviewedCC BYFull textHuman geneticsEurope PMC
Multi-Omics Integration Reveals Macrophage Lysosomal Remodeling as a Signature of Reparative Immunity in Human Lung Ischemia-Reperfusion Injury
Ming Li, Yixing Li, Hongyi Wang +6
American Journal of Transplantation21 Sep 2026Peer-reviewedCC BYSurgery & anaesthesiaHAL
Natural History and Clinical Outcomes of HBeAg-Negative Chronic Hepatitis B Patients in the “Grey Zone”: A Longitudinal Cohort Study
Yunling Xue, Mengyuan Liu, Guorui Wang +7
Journal of Clinical Medicine10 Oct 2026Peer-reviewedCC BY 4.0Epidemiology & public healthCrossref

Cite

BibTeX

@article{lau2026reply,
  title = {{Reply to ‘DR1-DR2 enrichment in HBeAg-negative chronic hepatitis B: integration hotspot or survivor signature?’}},
  author = {Daryl T-Y Lau and Ying-Hsiu Su and Haitao Guo},
  journal = {Gut},
  year = {2026},
  month = sep,
  doi = {10.1136/gutjnl-2026-340701},
  url = {https://doi.org/10.1136/gutjnl-2026-340701},
}

RIS

TY  - JOUR
TI  - Reply to ‘DR1-DR2 enrichment in HBeAg-negative chronic hepatitis B: integration hotspot or survivor signature?’
AU  - Daryl T-Y Lau
AU  - Ying-Hsiu Su
AU  - Haitao Guo
PY  - 2026
DA  - 2026/09/29
JO  - Gut
DO  - 10.1136/gutjnl-2026-340701
UR  - https://doi.org/10.1136/gutjnl-2026-340701
SN  - 0017-5749
SN  - 1468-3288
ER  -

Related

Cite